Names and pronunciation
(de-sye′ta-been/sed′az-ure′i-deen) Inqovi
PDF page 357
Loading InternPractice…
Drug reference
(de-sye′ta-been/sed′az-ure′i-deen) Inqovi
PDF page 357
Func. class.: Antineoplastic, antime- tabolite
PDF page 357
USES: Treatment of myelodysplastic syndromes (MDSs)
PDF page 357
CONTRAINDICATIONS: Hypersensitivity
PDF page 357
DOSAGE AND ROUTES • Adult: PO 35 mg decitabine/100 mg cedazuridine daily × 5 days of each 28-day cycle, complete at least 4 cycles
PDF page 357
Available forms: Tablets 35-100 mg
PDF page 357
• Adult: PO 35 mg decitabine/100 mg cedazuridine daily × 5 days of each 28-day cycle, complete at least 4 cycles
PDF page 357